Inhibitory pathways in the circular muscle of rat jejunum

Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2004-09, Vol.143 (1), p.107-118
Hauptverfasser: Vanneste, Gwen, Robberecht, Patrick, Lefebvre, Romain A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118
container_issue 1
container_start_page 107
container_title British journal of pharmacology
container_volume 143
creator Vanneste, Gwen
Robberecht, Patrick
Lefebvre, Romain A
description Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum. Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M). NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M). Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ. The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence. EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38. These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels. British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918
doi_str_mv 10.1038/sj.bjp.0705918
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>984049751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</originalsourceid><addsrcrecordid>eNqFkL1PwzAUxC0EglJYGVGExJjyXhzH9oIEFV8SEgwwW67jUEdpUuyEqv89qRpRmJjecL93dzpCzhAmCFRchXIyK5cT4MAkij0ywpRnMaMC98kIAHiMKMQROQ6hBOhFzg7JETIKSSbSEZFP9dzNXNv4dbTU7Xyl1yFyddTObWScN12lfbTogqls1BSR121U2rKru8UJOSh0FezpcMfk_f7ubfoYP788PE1vnmPDGJUxZRnLpUWdFpCnIssZJDkAw1khgWumacqRGmG4RSZ4hiK3hhtTCG21kEDH5Hrru-xmC5sbW7deV2rp3UL7tWq0U3-V2s3VR_OlkHGWcNkbXAwGvvnsbGhV2XS-7jurBDkKmeAmZbKFjG9C8Lb4CUBQm6VVKFW_tBqW7h_Of9fa4cO0PXA5ADoYXRVe18aFHZdhwhPKe45uuZWr7PqfWHX7-phlTNJv3WOXtg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217189210</pqid></control><display><type>article</type><title>Inhibitory pathways in the circular muscle of rat jejunum</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Wiley Free Archive</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</creator><creatorcontrib>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</creatorcontrib><description>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum. Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M). NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M). Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ. The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence. EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38. These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels. British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0705918</identifier><identifier>PMID: 15302684</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenosine Triphosphate - pharmacology ; Adenosine Triphosphate - physiology ; Animals ; Apamin - pharmacology ; ATP ; Autonomic Nervous System - drug effects ; Biological and medical sciences ; cGMP ; Cyclic GMP - physiology ; Electric Stimulation ; Isometric Contraction - drug effects ; Jejunal motility ; Jejunum - drug effects ; Jejunum - innervation ; Male ; Medical sciences ; Methacholine Chloride - pharmacology ; Muscarinic Agonists - pharmacology ; Muscle Contraction - drug effects ; Muscle Contraction - physiology ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; NANC ; Nerve Growth Factors - pharmacology ; Nerve Growth Factors - physiology ; Neuropeptides - pharmacology ; Neuropeptides - physiology ; Neurotransmitter Agents - pharmacology ; Neurotransmitter Agents - physiology ; nitric oxide ; Nitric Oxide - pharmacology ; Nitric Oxide - physiology ; PACAP ; Pharmacology. Drug treatments ; Pituitary Adenylate Cyclase-Activating Polypeptide ; Potassium Channels, Calcium-Activated - drug effects ; rat (Wistar–Han) ; Rats ; Rats, Wistar ; SK channels ; Small-Conductance Calcium-Activated Potassium Channels ; Synaptic Transmission - drug effects ; Tetrodotoxin - pharmacology ; Vasoactive Intestinal Peptide - pharmacology ; VIP</subject><ispartof>British journal of pharmacology, 2004-09, Vol.143 (1), p.107-118</ispartof><rights>2004 British Pharmacological Society</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Sep 2004</rights><rights>Copyright 2004, Nature Publishing Group 2004 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</citedby><cites>FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575279/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575279/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16127237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15302684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vanneste, Gwen</creatorcontrib><creatorcontrib>Robberecht, Patrick</creatorcontrib><creatorcontrib>Lefebvre, Romain A</creatorcontrib><title>Inhibitory pathways in the circular muscle of rat jejunum</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum. Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M). NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M). Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ. The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence. EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38. These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels. British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</description><subject>Adenosine Triphosphate - pharmacology</subject><subject>Adenosine Triphosphate - physiology</subject><subject>Animals</subject><subject>Apamin - pharmacology</subject><subject>ATP</subject><subject>Autonomic Nervous System - drug effects</subject><subject>Biological and medical sciences</subject><subject>cGMP</subject><subject>Cyclic GMP - physiology</subject><subject>Electric Stimulation</subject><subject>Isometric Contraction - drug effects</subject><subject>Jejunal motility</subject><subject>Jejunum - drug effects</subject><subject>Jejunum - innervation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacholine Chloride - pharmacology</subject><subject>Muscarinic Agonists - pharmacology</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle Contraction - physiology</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>NANC</subject><subject>Nerve Growth Factors - pharmacology</subject><subject>Nerve Growth Factors - physiology</subject><subject>Neuropeptides - pharmacology</subject><subject>Neuropeptides - physiology</subject><subject>Neurotransmitter Agents - pharmacology</subject><subject>Neurotransmitter Agents - physiology</subject><subject>nitric oxide</subject><subject>Nitric Oxide - pharmacology</subject><subject>Nitric Oxide - physiology</subject><subject>PACAP</subject><subject>Pharmacology. Drug treatments</subject><subject>Pituitary Adenylate Cyclase-Activating Polypeptide</subject><subject>Potassium Channels, Calcium-Activated - drug effects</subject><subject>rat (Wistar–Han)</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>SK channels</subject><subject>Small-Conductance Calcium-Activated Potassium Channels</subject><subject>Synaptic Transmission - drug effects</subject><subject>Tetrodotoxin - pharmacology</subject><subject>Vasoactive Intestinal Peptide - pharmacology</subject><subject>VIP</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkL1PwzAUxC0EglJYGVGExJjyXhzH9oIEFV8SEgwwW67jUEdpUuyEqv89qRpRmJjecL93dzpCzhAmCFRchXIyK5cT4MAkij0ywpRnMaMC98kIAHiMKMQROQ6hBOhFzg7JETIKSSbSEZFP9dzNXNv4dbTU7Xyl1yFyddTObWScN12lfbTogqls1BSR121U2rKru8UJOSh0FezpcMfk_f7ubfoYP788PE1vnmPDGJUxZRnLpUWdFpCnIssZJDkAw1khgWumacqRGmG4RSZ4hiK3hhtTCG21kEDH5Hrru-xmC5sbW7deV2rp3UL7tWq0U3-V2s3VR_OlkHGWcNkbXAwGvvnsbGhV2XS-7jurBDkKmeAmZbKFjG9C8Lb4CUBQm6VVKFW_tBqW7h_Of9fa4cO0PXA5ADoYXRVe18aFHZdhwhPKe45uuZWr7PqfWHX7-phlTNJv3WOXtg</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Vanneste, Gwen</creator><creator>Robberecht, Patrick</creator><creator>Lefebvre, Romain A</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>200409</creationdate><title>Inhibitory pathways in the circular muscle of rat jejunum</title><author>Vanneste, Gwen ; Robberecht, Patrick ; Lefebvre, Romain A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5539-3565d9e1a4f0d486d502d0051bf907a5a34713c8c7e1587618dec7ccf8aea8903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenosine Triphosphate - pharmacology</topic><topic>Adenosine Triphosphate - physiology</topic><topic>Animals</topic><topic>Apamin - pharmacology</topic><topic>ATP</topic><topic>Autonomic Nervous System - drug effects</topic><topic>Biological and medical sciences</topic><topic>cGMP</topic><topic>Cyclic GMP - physiology</topic><topic>Electric Stimulation</topic><topic>Isometric Contraction - drug effects</topic><topic>Jejunal motility</topic><topic>Jejunum - drug effects</topic><topic>Jejunum - innervation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacholine Chloride - pharmacology</topic><topic>Muscarinic Agonists - pharmacology</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle Contraction - physiology</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>NANC</topic><topic>Nerve Growth Factors - pharmacology</topic><topic>Nerve Growth Factors - physiology</topic><topic>Neuropeptides - pharmacology</topic><topic>Neuropeptides - physiology</topic><topic>Neurotransmitter Agents - pharmacology</topic><topic>Neurotransmitter Agents - physiology</topic><topic>nitric oxide</topic><topic>Nitric Oxide - pharmacology</topic><topic>Nitric Oxide - physiology</topic><topic>PACAP</topic><topic>Pharmacology. Drug treatments</topic><topic>Pituitary Adenylate Cyclase-Activating Polypeptide</topic><topic>Potassium Channels, Calcium-Activated - drug effects</topic><topic>rat (Wistar–Han)</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>SK channels</topic><topic>Small-Conductance Calcium-Activated Potassium Channels</topic><topic>Synaptic Transmission - drug effects</topic><topic>Tetrodotoxin - pharmacology</topic><topic>Vasoactive Intestinal Peptide - pharmacology</topic><topic>VIP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vanneste, Gwen</creatorcontrib><creatorcontrib>Robberecht, Patrick</creatorcontrib><creatorcontrib>Lefebvre, Romain A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vanneste, Gwen</au><au>Robberecht, Patrick</au><au>Lefebvre, Romain A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory pathways in the circular muscle of rat jejunum</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2004-09</date><risdate>2004</risdate><volume>143</volume><issue>1</issue><spage>107</spage><epage>118</epage><pages>107-118</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>Conflicting data have been reported on the contribution of nitric oxide (NO) to inhibitory neurotransmission in rat jejunum. Therefore, the mechanism of relaxation and contribution to inhibitory neurotransmission of NO, adenosine 5′‐triphosphate (ATP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating peptide (PACAP) was examined in the circular muscle of Wistar–Han rat jejunum. Mucosa‐free circular muscle strips were precontracted with methacholine in the presence of guanethidine and exposed to electrical field stimulation (EFS) and exogenous NO, ATP, VIP and PACAP. All stimuli induced reduction of tone and inhibition of phasic motility. Only electrically induced responses were sensitive to tetrodotoxin (3 × 10−6M). NO (10−6–10−4M)‐induced concentration‐dependent relaxations that were inhibited by the soluble guanylyl cyclase inhibitor 1H‐[1,2,4]‐oxadiazolo‐[4,3‐a]‐quinoxalin‐1‐one (ODQ; 10−5M) and the small conductance Ca2+‐activated K+‐channel blocker apamin (APA; 3 × 10−8M). Relaxations elicited by exogenous ATP (10−4–10−3M) were inhibited by the P2Y purinoceptor antagonist reactive blue 2 (RB2; 3 × 10−4M), but not by APA and ODQ. The inhibitory responses evoked by 10−7M VIP and 3 × 10−8M PACAP were decreased by the selective PAC1 receptor antagonist PACAP6–38 (3 × 10−6M) and APA. The VPAC2 receptor antagonist PG99‐465 (3 × 10−7M) reduced relaxations caused by VIP, but not those by PACAP, while the VPAC1 receptor antagonist PG97‐269 (3 × 10−7M) had no influence. EFS‐induced relaxations were inhibited by the NO‐synthase inhibitor Nω‐nitro‐L‐arginine methyl ester (3 × 10−4M), ODQ and APA, but not by RB2, PG97‐269, PG99‐465 and PACAP6–38. These results suggest that NO is the main inhibitory neurotransmitter in the circular muscle of Wistar–Han rat jejunum acting through a rise in cyclic guanosine monophosphate levels and activation of small conductance Ca2+‐dependent K+ channels. British Journal of Pharmacology (2004) 143, 107–118. doi:10.1038/sj.bjp.0705918</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15302684</pmid><doi>10.1038/sj.bjp.0705918</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2004-09, Vol.143 (1), p.107-118
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575279
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Wiley Free Archive; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adenosine Triphosphate - pharmacology
Adenosine Triphosphate - physiology
Animals
Apamin - pharmacology
ATP
Autonomic Nervous System - drug effects
Biological and medical sciences
cGMP
Cyclic GMP - physiology
Electric Stimulation
Isometric Contraction - drug effects
Jejunal motility
Jejunum - drug effects
Jejunum - innervation
Male
Medical sciences
Methacholine Chloride - pharmacology
Muscarinic Agonists - pharmacology
Muscle Contraction - drug effects
Muscle Contraction - physiology
Muscle, Smooth - drug effects
Muscle, Smooth - innervation
NANC
Nerve Growth Factors - pharmacology
Nerve Growth Factors - physiology
Neuropeptides - pharmacology
Neuropeptides - physiology
Neurotransmitter Agents - pharmacology
Neurotransmitter Agents - physiology
nitric oxide
Nitric Oxide - pharmacology
Nitric Oxide - physiology
PACAP
Pharmacology. Drug treatments
Pituitary Adenylate Cyclase-Activating Polypeptide
Potassium Channels, Calcium-Activated - drug effects
rat (Wistar–Han)
Rats
Rats, Wistar
SK channels
Small-Conductance Calcium-Activated Potassium Channels
Synaptic Transmission - drug effects
Tetrodotoxin - pharmacology
Vasoactive Intestinal Peptide - pharmacology
VIP
title Inhibitory pathways in the circular muscle of rat jejunum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A54%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20pathways%20in%20the%20circular%20muscle%20of%20rat%20jejunum&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Vanneste,%20Gwen&rft.date=2004-09&rft.volume=143&rft.issue=1&rft.spage=107&rft.epage=118&rft.pages=107-118&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0705918&rft_dat=%3Cproquest_pubme%3E984049751%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217189210&rft_id=info:pmid/15302684&rfr_iscdi=true